Comparison study among FM/BUD (Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB (Salbutamol) about bronchodilating effect part and onset of relief of dyspnea.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Jul 2013
At a glance
- Drugs Budesonide/formoterol (Primary) ; Salbutamol (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Asthma; Bronchoconstriction
- Focus Therapeutic Use
- 16 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 22 Jan 2013 New trial record